2-[2-(1-Methylindol-5-yl)-5-[5-[4-methyl-5-(1-methylindol-5-yl)thiophen-2-yl]thiophen-2-yl]thiophen-3-yl]acetic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 双噻吩和低聚噻吩
• 英文名称: 2-[2-(1-Methylindol-5-yl)-5-[5-[4-methyl-5-(1-methylindol-5-yl)thiophen-2-yl]thiophen-2-yl]thiophen-3-yl]acetic acid
• 英文别名: 2-[2-(1-methylindol-5-yl)-5-[5-[4-methyl-5-(1-methylindol-5-yl)thiophen-2-yl]thiophen-2-yl]thiophen-3-yl]acetic acid
• 化学式: C₃₃H₂₆N₂O₂S₃
• 分子量: 578.8
• InChiKey: AKNLYPHXJJVWLW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.7
• 重原子数：
  40
• 可旋转键数：
  6
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  132
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• NOVEL COMPOUNDS AND THEIR USE IN THERAPY
  申请人：Asberg Peter

  公开号：US20140135322A1

  公开（公告）日：2014-05-15

  The present invention relates to novel chemical compounds formula (I) (C) n —B-(A) m -B—(C) n (I) wherein m is 0 or 1, and n is independently 0, 1, 2 or 3, A, each B and each C are independently selected from phenylene and five- and six-membered heteroaromatic rings, and for a terminal ring B or C also from bicyclic heteroaromatic fused rings having seven to ten ring members, wherein the bond between at least two of the rings A to C may be replaced by a carbonyl group (—CO—), wherein at least two of the rings A to C are substituted with one or two groups R, and wherein each ring A to C further optionally is substituted with one or two groups R 1 . The compounds are useful in therapy, especially therapy of a mammal suffering from a disease involving misfolded or aggregated forms of proteins.

  本发明涉及新型化合物的公式(I)(C)n-B-(A)m-B-(C)n(I)，其中m为0或1，n独立地为0、1、2或3，A、每个B和每个C都是从苯基和五-六元杂环芳香环中独立选择的，对于末端环B或C，还可以从具有七到十个环成员的双环杂环融合环中选择，其中至少两个环A到C之间的键可以被羰基（-CO-）所取代，至少两个环A到C被取代为一个或两个基团R，每个环A到C还可以选择地被取代为一个或两个基团R1。这些化合物在治疗方面有用，特别是治疗患有涉及蛋白质错误折叠或聚集形式的哺乳动物疾病。
• US9359311B2
  申请人：——

  公开号：US9359311B2

  公开（公告）日：2016-06-07